Next Article in Journal
Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?
Next Article in Special Issue
Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy
Previous Article in Journal
Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells
Previous Article in Special Issue
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis
 
 
Editorial

Article Versions Notes

Cancers 2022, 14(18), 4497; https://doi.org/10.3390/cancers14184497
Action Date Notes Link
article xml file uploaded 16 September 2022 12:31 CEST Original file -
article xml uploaded. 16 September 2022 12:31 CEST Update https://www.mdpi.com/2072-6694/14/18/4497/xml
article pdf uploaded. 16 September 2022 12:31 CEST Version of Record https://www.mdpi.com/2072-6694/14/18/4497/pdf
article html file updated 16 September 2022 12:32 CEST Original file https://www.mdpi.com/2072-6694/14/18/4497/html
Back to TopTop